Julie Jeansonne
Papers
1
Total Citations
4
H-Index
1
About
Julie Jeansonne is a clinician-researcher whose work centers on rare gynecologic malignancies and the complex intersection of pregnancy with cancer diagnosis and treatment. Her most cited study, a 2022 case report on uterine perivascular epithelioid cell tumor (PEComa), exemplifies her focus on these exceptionally uncommon neoplasms—tumors that show both smooth muscle and melanocytic differentiation. In this landmark case, she documented a 21-year-old primigravida whose PEComa was discovered incidentally during a cesarean section, highlighting the profound challenges pregnancy poses for determining prognosis and optimal management. While her citation count is modest, reflecting the niche nature of her subject matter, Jeansonne’s contribution is significant for providing critical clinical guidance on a tumor so rare that few standardized treatment protocols exist. Her work underscores the need for individualized care in pregnant patients with mesenchymal uterine tumors, offering a valuable reference for oncologists and maternal-fetal medicine specialists navigating these high-stakes, understudied scenarios. Through detailed case analysis, Jeansonne advances understanding of how pregnancy can alter tumor presentation and therapeutic decision-making.
Research Focus
Key Achievements
Top Papers
- 1